Fragile X mental retardation protein and synaptic plasticity

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Sidorov, Michael S ^a   Auerbach, Benjamin D ^a   Bear, Mark F ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

FMRP; Fragile X; Long term depression; Long term potentiation; Metabotropic glutamate receptor; Protein synthesis; Synaptic plasticity

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV4.2; UNCLASSIFIED DRUG;

BRAIN FUNCTION; DEPRESSION; FRAGILE X SYNDROME; KNOCKOUT MOUSE; LEARNING; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; LEARNING; LONG-TERM POTENTIATION; NEURONAL PLASTICITY; PROTEIN BIOSYNTHESIS; SYNAPSES;

EID: 84875850679     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-15     Document Type: Review

References (129)

1. The molecular biology of memory storage: a dialogue between genes and synapses. Kandel ER, Science 2001 294 1030 1038 10.1126/science.1067020 11691980 (Pubitemid 33041851)
2. Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus. Steward O, Levy WB, J Neurosci 1982 2 284 291 7062109 (Pubitemid 12098607)
3. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Kang H, Schuman EM, Science 1996 273 1402 1406 10.1126/science.273.5280.1402 8703078 (Pubitemid 26296531)
4. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Huber KM, Kayser MS, Bear MF, Science 2000 288 1254 1257 10.1126/science.288.5469.1254 10818003 (Pubitemid 30367205)
5. Theta frequency stimulation induces a local form of late phase LTP in the CA1 region of the hippocampus. Huang YY, Kandel ER, Learn Mem 2005 12 587 593 10.1101/lm.98905 16287724 (Pubitemid 41770082)
6. Evidence that fragile X mental retardation protein is a negative regulator of translation. Laggerbauer B, Ostareck D, Keidel EM, Ostareck-Lederer A, Fischer U, Hum Mol Genet 2001 10 329 338 10.1093/hmg/10.4.329 11157796 (Pubitemid 32166544)
7. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Li Z, Zhang Y, Ku L, Wilkinson KD, Warren ST, Feng Y, Nucleic Acids Res 2001 29 2276 2283 10.1093/nar/29.11.2276 11376146 (Pubitemid 32514930)
8. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Huber KM, Gallagher SM, Warren ST, Bear MF, Proc Natl Acad Sci USA 2002 99 7746 7750 10.1073/pnas.122205699 12032354 (Pubitemid 34568762)
9. Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse. Qin M, Kang J, Burlin TV, Jiang C, Smith CB, J Neurosci 2005 25 5087 5095 10.1523/JNEUROSCI.0093-05.2005 15901791 (Pubitemid 40712853)
10. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Cell 2011 146 247 261 10.1016/j.cell.2011.06. 013 21784246
11. Fmr1 knockout mice: a model to study fragile X mental retardation. Consortium TD-BFX, Cell 1994 78 23 33 8033209
12. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. Osterweil EK, Krueger DD, Reinhold K, Bear MF, J Neurosci 2010 30 15616 15627 10.1523/JNEUROSCI.3888-10.2010 21084617
13. The mGluR theory of fragile X mental retardation. Bear MF, Huber KM, Warren ST, Trends Neurosci 2004 27 370 377 10.1016/j.tins.2004.04.009 15219735 (Pubitemid 38829251)
14. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E, Neuron 2012 76 325 337 10.1016/j.neuron.2012.07.022 23083736
15. The pathophysiology of fragile X (and what it teaches us about synapses). Bhakar AL, Dolen G, Bear MF, Annu Rev Neurosci 2012 35 417 443 10.1146/annurev-neuro-060909-153138 22483044
16. Transcription, translation and fragile X syndrome. Garber K, Smith KT, Reines D, Warren ST, Curr Opin Genet Dev 2006 16 270 275 10.1016/j.gde.2006.04. 010 16647847
17. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Bassell GJ, Warren ST, Neuron 2008 60 201 214 10.1016/j.neuron.2008.10.004 18957214
18. The state of synapses in fragile X syndrome. Pfeiffer BE, Huber KM, Neuroscientist 2009 15 549 567 10.1177/1073858409333075 19325170
19. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Krueger DD, Bear MF, Annu Rev Med 2011 62 411 429 10.1146/annurev-med- 061109-134644 21090964
20. FMR1 protein: conserved RNP family domains and selective RNA binding. Ashley CT Jr, Wilkinson KD, Reines D, Warren ST, Science 1993 262 563 566 10.1126/science.7692601 7692601 (Pubitemid 23350668)
21. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G, Cell 1993 74 291 298 10.1016/0092-8674(93)90420-U 7688265 (Pubitemid 23221705)
22. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, De Rubeis S, Di Marino D, Mohr E, Massimi M, Falconi M, Cell 2008 134 1042 1054 10.1016/j.cell.2008.07.031 18805096
23. Fragile X mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal RiboNucleoProtein complexes [corrected]. El Fatimy R, Tremblay S, Dury AY, Solomon S, De Koninck P, Schrader JW, Khandjian EW, PLoS One 2012 7 39338 10.1371/journal.pone.0039338 22737234
24. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Santoro MR, Bray SM, Warren ST, Annu Rev Pathol 2012 7 219 245 10.1146/annurev-pathol-011811-132457 22017584
25. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Bagni C, Greenough WT, Nat Rev Neurosci 2005 6 376 387 15861180 (Pubitemid 40593483)
26. A mouse model of the human Fragile X syndrome I304N mutation. Zang JB, Nosyreva ED, Spencer CM, Volk LJ, Musunuru K, Zhong R, Stone EF, Yuva-Paylor LA, Huber KM, Paylor R, PLoS Genet 2009 5 1000758 10.1371/journal.pgen.1000758 20011099
27. A point mutation in the FMR-1 gene associated with fragile X mental retardation. De Boulle K, Verkerk AJ, Reyniers E, Vits L, Hendrickx J, Van Roy B, Van den Bos F, de Graaff E, Oostra BA, Willems PJ, Nat Genet 1993 3 31 35 10.1038/ng0193-31 8490650 (Pubitemid 23063285)
28. In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation. Coffee RL Jr, Williamson AJ, Adkins CM, Gray MC, Page TL, Broadie K, Hum Mol Genet 2012 21 900 915 10.1093/hmg/ddr527 22080836
29. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Muddashetty RS, Nalavadi VC, Gross C, Yao X, Xing L, Laur O, Warren ST, Bassell GJ, Mol Cell 2011 42 673 688 10.1016/j.molcel.2011.05.006 21658607
30. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Ceman S, O'Donnell WT, Reed M, Patton S, Pohl J, Warren ST, Hum Mol Genet 2003 12 3295 3305 10.1093/hmg/ddg350 14570712 (Pubitemid 37541075)
31. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT, Proc Natl Acad Sci USA 1997 94 5395 5400 10.1073/pnas.94.10.5395 9144248 (Pubitemid 27214794)
32. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Feng Y, Absher D, Eberhart DE, Brown V, Malter HE, Warren ST, Mol Cell 1997 1 109 118 10.1016/S1097- 2765(00)80012-X 9659908 (Pubitemid 127376398)
33. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. Antar LN, Afroz R, Dictenberg JB, Carroll RC, Bassell GJ, J Neurosci 2004 24 2648 2655 10.1523/JNEUROSCI.0099-04.2004 15028757 (Pubitemid 38380941)
34. The fragile X mental retardation protein-RNP granules show an mGluR-dependent localization in the post-synaptic spines. Ferrari F, Mercaldo V, Piccoli G, Sala C, Cannata S, Achsel T, Bagni C, Mol Cell Neurosci 2007 34 343 354 10.1016/j.mcn.2006.11.015 17254795 (Pubitemid 46330040)
35. Dendritic protein synthesis, synaptic plasticity, and memory. Sutton MA, Schuman EM, Cell 2006 127 49 58 10.1016/j.cell.2006.09.014 17018276 (Pubitemid 44466643)
36. Evidence for altered Fragile-X mental retardation protein expression in response to behavioral stimulation. Irwin SA, Swain RA, Christmon CA, Chakravarti A, Weiler IJ, Greenough WT, Neurobiol Learn Mem 2000 74 87 93 11001622 (Pubitemid 30167121)
37. Visual experience regulates transient expression and dendritic localization of fragile X mental retardation protein. Gabel LA, Won S, Kawai H, McKinney M, Tartakoff AM, Fallon JR, J Neurosci 2004 24 10579 10583 10.1523/JNEUROSCI.2185-04.2004 15564573 (Pubitemid 39557630)
38. Whisker stimulation-dependent translation of FMRP in the barrel cortex requires activation of type I metabotropic glutamate receptors. Todd PK, Malter JS, Mack KJ, Brain Res Mol Brain Res 2003 110 267 278 10.1016/S0169-328X(02) 00657-5 12591163 (Pubitemid 36184699)
39. Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons. Antar LN, Dictenberg JB, Plociniak M, Afroz R, Bassell GJ, Genes Brain Behav 2005 4 350 359 10.1111/j.1601-183X.2005.00128.x 16098134 (Pubitemid 41192447)
40. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ, Dev Cell 2008 14 926 939 10.1016/j.devcel.2008.04.003 18539120 (Pubitemid 351757204)
41. The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus. Palmer MJ, Irving AJ, Seabrook GR, Jane DE, Collingridge GL, Neuropharmacology 1997 36 1517 1532 10.1016/S0028-3908(97) 00181-0 9517422 (Pubitemid 28085911)
42. Activation of group 1 metabotropic glutamate receptors induces long-term depression of synaptic transmission in area CA1 of rat hippocampus. Huber KM, Bear MF, Soc Neurosci Abstr 1998 22
43. Chemical induction of mGluR5- and protein synthesis-dependent long-term depression in hippocampal area CA1. Huber KM, Roder JC, Bear MF, J Neurophysiol 2001 86 321 325 11431513 (Pubitemid 32623237)
44. Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells. Oliet SH, Malenka RC, Nicoll RA, Neuron 1997 18 969 982 10.1016/S0896-6273(00)80336-0 9208864 (Pubitemid 27274615)
45. Altered presynaptic vesicle release and cycling during mGluR-dependent LTD. Zakharenko SS, Zablow L, Siegelbaum SA, Neuron 2002 35 1099 1110 10.1016/S0896-6273(02)00898-X 12354399 (Pubitemid 35279537)
46. Developmental switch in synaptic mechanisms of hippocampal metabotropic glutamate receptor-dependent long-term depression. Nosyreva ED, Huber KM, J Neurosci 2005 25 2992 3001 10.1523/JNEUROSCI.3652-04.2005 15772359 (Pubitemid 40389257)
47. Co-activation of p38 mitogen-activated protein kinase and protein tyrosine phosphatase underlies metabotropic glutamate receptor-dependent long-term depression. Moult PR, Correa SA, Collingridge GL, Fitzjohn SM, Bashir ZI, J Physiol 2008 586 2499 2510 10.1113/jphysiol.2008.153122 18356198 (Pubitemid 351689808)
48. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Auerbach BD, Osterweil EK, Bear MF, Nature 2011 480 63 68 10.1038/nature10658 22113615
49. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E, Neuron 2006 51 441 454 10.1016/j.neuron.2006.07.005 16908410 (Pubitemid 44189802)
50. Internalization of ionotropic glutamate receptors in response to mGluR activation. Snyder EM, Philpot BD, Huber KM, Dong X, Fallon JR, Bear MF, Nat Neurosci 2001 4 1079 1085 10.1038/nn746 11687813 (Pubitemid 34116552)
51. Identification of sites for exponential translation in living dendrites. Job C, Eberwine J, Proc Natl Acad Sci USA 2001 98 13037 13042 10.1073/pnas.231485698 11606784 (Pubitemid 33051313)
52. Metabotropic glutamate receptors trigger postsynaptic protein synthesis. Weiler IJ, Greenough WT, Proc Natl Acad Sci USA 1993 90 7168 7171 10.1073/pnas.90.15.7168 8102206 (Pubitemid 23222410)
53. Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice. Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, Jaeschke G, Bear MF, Lindemann L, Neuron 2012 74 49 56 10.1016/j.neuron.2012.03. 009 22500629
54. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Koekkoek SK, Yamaguchi K, Milojkovic BA, Dortland BR, Ruigrok TJ, Maex R, De Graaf W, Smit AE, VanderWerf F, Bakker CE, Neuron 2005 47 339 352 10.1016/j.neuron.2005.07.005 16055059 (Pubitemid 41073876)
55. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Nakamoto M, Nalavadi V, Epstein MP, Narayanan U, Bassell GJ, Warren ST, Proc Natl Acad Sci USA 2007 104 15537 15542 10.1073/pnas.0707484104 17881561 (Pubitemid 47502952)
56. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. Nosyreva ED, Huber KM, J Neurophysiol 2006 95 3291 3295 10.1152/jn.01316.2005 16452252
57. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome. Zeier Z, Kumar A, Bodhinathan K, Feller JA, Foster TC, Bloom DC, Gene Ther 2009 16 1122 1129 10.1038/gt.2009.83 19571888
58. Correction of fragile X syndrome in mice. Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF, Neuron 2007 56 955 962 10.1016/j.neuron.2007.12.001 18093519 (Pubitemid 350251119)
59. Blockade of long-term potentiation in rat hippocampal CA1 region by inhibitors of protein synthesis. Stanton PK, Sarvey JM, J Neurosci 1984 4 3080 3088 6502226 (Pubitemid 15191177)
60. Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Frey U, Krug M, Reymann KG, Matthies H, Brain Res 1988 452 57 65 10.1016/0006-8993(88)90008-X 3401749
61. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST, Neuroscience 1999 94 185 192 10.1016/S0306-4522(99)00285-7 10613508 (Pubitemid 29457608)
62. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. Zhang J, Hou L, Klann E, Nelson DL, J Neurophysiol 2009 101 2572 2580 19244359
63. Properties and mechanisms of LTP maintenance. Abraham WC, Williams JM, Neuroscientist 2003 9 463 474 10.1177/1073858403259119 14678579 (Pubitemid 37467359)
64. Anisomycin blocks the late phase of long-term potentiation in the dentate gyrus of freely moving rats. Krug M, Lossner B, Ott T, Brain Res Bull 1984 13 39 42 10.1016/0361-9230(84)90005-4 6089972 (Pubitemid 14013179)
65. Requirement of a critical period of transcription for induction of a late phase of LTP. Nguyen PV, Abel T, Kandel ER, Science 1994 265 1104 1107 10.1126/science.8066450 8066450 (Pubitemid 24293080)
66. Translational control by MAPK signaling in long-term synaptic plasticity and memory. Kelleher RJ 3rd, Govindarajan A, Jung HY, Kang H, Tonegawa S, Cell 2004 116 467 479 10.1016/S0092-8674(04)00115-1 15016380 (Pubitemid 38366322)
67. Facilitation of long-term potentiation by prior activation of metabotropic glutamate receptors. Cohen AS, Abraham WC, J Neurophysiol 1996 76 953 962 8871210 (Pubitemid 26284579)
68. Metabotropic glutamate receptors trigger homosynaptic protein synthesis to prolong long-term potentiation. Raymond CR, Thompson VL, Tate WP, Abraham WC, J Neurosci 2000 20 969 976 10648701 (Pubitemid 30220453)
69. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis. Auerbach BD, Bear MF, J Neurophysiol 2010 104 1047 1051 10.1152/jn.00449.2010 20554840
70. Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. Lauterborn JC, Rex CS, Kramar E, Chen LY, Pandyarajan V, Lynch G, Gall CM, J Neurosci 2007 27 10685 10694 10.1523/JNEUROSCI.2624-07.2007 17913902 (Pubitemid 47535868)
71. Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs. Markram H, Lubke J, Frotscher M, Sakmann B, Science 1997 275 213 215 10.1126/science.275.5297.213 8985014 (Pubitemid 27034762)
72. Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength, and postsynaptic cell type. Bi GQ, Poo MM, J Neurosci 1998 18 10464 10472 9852584
73. Early postnatal plasticity in neocortex of Fmr1 knockout mice. Desai NS, Casimiro TM, Gruber SM, Vanderklish PW, J Neurophysiol 2006 96 1734 1745 10.1152/jn.00221.2006 16823030 (Pubitemid 44527431)
74. Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1. Meredith RM, Holmgren CD, Weidum M, Burnashev N, Mansvelder HD, Neuron 2007 54 627 638 10.1016/j.neuron.2007.04.028 17521574 (Pubitemid 46756139)
75. The self-tuning neuron: synaptic scaling of excitatory synapses. Turrigiano GG, Cell 2008 135 422 435 10.1016/j.cell.2008.10.008 18984155
76. Rapid synaptic scaling induced by changes in postsynaptic firing. Ibata K, Sun Q, Turrigiano GG, Neuron 2008 57 819 826 10.1016/j.neuron.2008.02.031 18367083 (Pubitemid 351400640)
77. Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. Sutton MA, Ito HT, Cressy P, Kempf C, Woo JC, Schuman EM, Cell 2006 125 785 799 10.1016/j.cell.2006.03.040 16713568
78. Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid. Soden ME, Chen L, J Neurosci 2010 30 16910 16921 10.1523/JNEUROSCI.3660-10.2010 21159962
79. Activity-dependent scaling of quantal amplitude in neocortical neurons. Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB, Nature 1998 391 892 896 10.1038/36103 9495341 (Pubitemid 28157666)
80. Homeostatic scaling requires group I mGluR activation mediated by Homer1a. Hu JH, Park JM, Park S, Xiao B, Dehoff MH, Kim S, Hayashi T, Schwarz MK, Huganir RL, Seeburg PH, Neuron 2010 68 1128 1142 10.1016/j.neuron.2010.11. 008 21172614
81. MeCP2 phosphorylation is required for modulating synaptic scaling through mGluR5. Zhong X, Li H, Chang Q, J Neurosci 2012 32 12841 12847 10.1523/JNEUROSCI.2784-12.2012 22973007
82. Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation. Volk LJ, Pfeiffer BE, Gibson JR, Huber KM, J Neurosci 2007 27 11624 11634 10.1523/JNEUROSCI.2266-07.2007 17959805 (Pubitemid 350006892)
83. Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus. Connor SA, Hoeffer CA, Klann E, Nguyen PV, Learn Mem 2011 18 207 220 10.1101/lm.2043811 21430043
84. Long-term potentiation in the hippocampus of fragile X knockout mice. Godfraind JM, Reyniers E, De Boulle K, D'Hooge R, De Deyn PP, Bakker CE, Oostra BA, Kooy RF, Willems PJ, Am J Med Genet 1996 64 246 251 10.1002/(SICI)1096- 8628(19960809)64:2<246::AID-AJMG2>3.0.CO;2-S 8844057
85. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Li J, Pelletier MR, Perez Velazquez JL, Carlen PL, Mol Cell Neurosci 2002 19 138 151 10.1006/mcne.2001. 1085 11860268 (Pubitemid 34211895)
86. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, Choi SY, Chattarji S, Tonegawa S, Proc Natl Acad Sci USA 2007 104 11489 11494 10.1073/pnas.0705003104 17592139 (Pubitemid 47175167)
87. Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. Zhao MG, Toyoda H, Ko SW, Ding HK, Wu LJ, Zhuo M, J Neurosci 2005 25 7385 7392 10.1523/JNEUROSCI.1520-05.2005 16093389 (Pubitemid 41129811)
88. Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome. Suvrathan A, Hoeffer CA, Wong H, Klann E, Chattarji S, Proc Natl Acad Sci USA 2010 107 11591 11596 10.1073/pnas.1002262107 20534533
89. Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Wilson BM, Cox CL, Proc Natl Acad Sci USA 2007 104 2454 2459 10.1073/pnas.0610875104 17287348 (Pubitemid 46394340)
90. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Cell 2001 107 477 487 10.1016/S0092-8674(01)00568-2 11719188 (Pubitemid 33152783)
91. Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Jung H, Yoon BC, Holt CE, Nat Rev Neurosci 2012 13 308 324 22498899
92. Presynaptic translation: stepping out of the postsynaptic shadow. Akins MR, Berk-Rauch HE, Fallon JR, Front Neural Circuits 2009 3 17 19915727
93. Fragile X mental retardation protein (FMRP) and the spinal sensory system. Price TJ, Melemedjian OK, Results Probl Cell Differ 2012 54 41 59 10.1007/978-3-642-21649-7-4 22009347
94. Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR. Price TJ, Rashid MH, Millecamps M, Sanoja R, Entrena JM, Cervero F, J Neurosci 2007 27 13958 13967 10.1523/JNEUROSCI.4383-07.2007 18094233 (Pubitemid 351377872)
95. Characterization of the role of microtubule-associated protein 1B in metabotropic glutamate receptor-mediated endocytosis of AMPA receptors in hippocampus. Davidkova G, Carroll RC, J Neurosci 2007 27 13273 13278 10.1523/JNEUROSCI.3334-07.2007 18045921 (Pubitemid 350220475)
96. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Lu R, Wang H, Liang Z, Ku L, O'Donnell WT, Li W, Warren ST, Feng Y, Proc Natl Acad Sci USA 2004 101 15201 15206 10.1073/pnas.0404995101 15475576 (Pubitemid 39391742)
97. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB, Cell 2001 107 489 499 10.1016/S0092-8674(01)00566-9 11719189 (Pubitemid 33152784)
98. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Zalfa F, Giorgi M, Primerano B, Moro A, Di Penta A, Reis S, Oostra B, Bagni C, Cell 2003 112 317 327 10.1016/S0092-8674(03)00079-5 12581522 (Pubitemid 36183653)
99. Expression changes of microtubule associated protein 1B in the brain of Fmr1 knockout mice. Wei ZX, Yi YH, Sun WW, Wang R, Su T, Bai YJ, Liao WP, Neurosci Bull 2007 23 203 208 10.1007/s12264-007-0030-1 17687394 (Pubitemid 47477551)
100. Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Chowdhury S, Shepherd JD, Okuno H, Lyford G, Petralia RS, Plath N, Kuhl D, Huganir RL, Worley PF, Neuron 2006 52 445 459 10.1016/j.neuron.2006.08.033 17088211 (Pubitemid 44667430)
101. Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate. Waung MW, Pfeiffer BE, Nosyreva ED, Ronesi JA, Huber KM, Neuron 2008 59 84 97 10.1016/j.neuron.2008.05. 014 18614031 (Pubitemid 351905854)
102. Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Park S, Park JM, Kim S, Kim JA, Shepherd JD, Smith-Hicks CL, Chowdhury S, Kaufmann W, Kuhl D, Ryazanov AG, Neuron 2008 59 70 83 10.1016/j.neuron.2008.05.023 18614030 (Pubitemid 351905855)
103. New views of Arc, a master regulator of synaptic plasticity. Shepherd JD, Bear MF, Nat Neurosci 2011 14 279 284 10.1038/nn.2708 21278731
104. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C, Mao X, Engelsberg A, Mahlke C, Welzl H, Neuron 2006 52 437 444 10.1016/j.neuron. 2006.08.024 17088210 (Pubitemid 44755254)
105. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression. Niere F, Wilkerson JR, Huber KM, J Neurosci 2012 32 5924 5936 10.1523/JNEUROSCI.4650-11.2012 22539853
106. On BC1 RNA and the fragile X mental retardation protein. Iacoangeli A, Rozhdestvensky TS, Dolzhanskaya N, Tournier B, Schutt J, Brosius J, Denman RB, Khandjian EW, Kindler S, Tiedge H, Proc Natl Acad Sci USA 2008 105 734 739 10.1073/pnas.0710991105 18184799 (Pubitemid 351171777)
107. The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. Zhang Y, Venkitaramani DV, Gladding CM, Kurup P, Molnar E, Collingridge GL, Lombroso PJ, J Neurosci 2008 28 10561 10566 10.1523/JNEUROSCI.2666-08.2008 18923032
108. Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders. Goebel-Goody SM, Baum M, Paspalas CD, Fernandez SM, Carty NC, Kurup P, Lombroso PJ, Pharmacol Rev 2012 64 65 87 10.1124/pr.110.003053 22090472
109. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model. Goebel-Goody SM, Wilson-Wallis ED, Royston S, Tagliatela SM, Naegele JR, Lombroso PJ, Genes Brain Behav 2012 11 586 600 10.1111/j.1601-183X.2012.00781.x 22405502
110. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. Westmark CJ, Malter JS, PLoS Biol 2007 5 52 10.1371/journal.pbio.0050052 17298186 (Pubitemid 46422979)
111. Reversal of fragile X phenotypes by manipulation of AbetaPP/Abeta levels in Fmr1KO mice. Westmark CJ, Westmark PR, O'Riordan KJ, Ray BC, Hervey CM, Salamat MS, Abozeid SH, Stein KM, Stodola LA, Tranfaglia M, PLoS One 2011 6 26549 10.1371/journal.pone.0026549 22046307
112. Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery. Nadif Kasri N, Nakano-Kobayashi A, Van Aelst L, Neuron 2011 72 300 315 10.1016/j.neuron.2011.09.001 22017989
113. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. Muddashetty RS, Kelic S, Gross C, Xu M, Bassell GJ, J Neurosci 2007 27 5338 5348 10.1523/JNEUROSCI.0937-07.2007 17507556 (Pubitemid 46790157)
114. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Todd PK, Mack KJ, Malter JS, Proc Natl Acad Sci USA 2003 100 14374 14378 10.1073/pnas. 2336265100 14614133 (Pubitemid 37499244)
115. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Zalfa F, Eleuteri B, Dickson KS, Mercaldo V, De Rubeis S, di Penta A, Tabolacci E, Chiurazzi P, Neri G, Grant SG, Bagni C, Nat Neurosci 2007 10 578 587 10.1038/nn1893 17417632 (Pubitemid 46652449)
116. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, Warren ST, Bassell GJ, J Neurosci 2010 30 10624 10638 10.1523/JNEUROSCI.0402-10.2010 20702695
117. Fragile X syndrome: mechanistic insights and therapeutic avenues regarding the role of potassium channels. Lee HY, Jan LY, Curr Opin Neurobiol 2012 22 1 8 10.1016/j.conb.2012.01.004 22305967
118. Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein. Lee HY, Ge WP, Huang W, He Y, Wang GX, Rowson-Baldwin A, Smith SJ, Jan YN, Jan LY, Neuron 2011 72 630 642 10.1016/j.neuron.2011.09.033 22099464
119. Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2. Gross C, Yao X, Pong DL, Jeromin A, Bassell GJ, J Neurosci 2011 31 5693 5698 10.1523/JNEUROSCI.6661-10. 2011 21490210
120. Fragile X mental retardation protein is required for rapid experience-dependent regulation of the potassium channel Kv3.1b. Strumbos JG, Brown MR, Kronengold J, Polley DB, Kaczmarek LK, J Neurosci 2010 30 10263 10271 10.1523/JNEUROSCI.1125-10.2010 20685971
121. Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack. Brown MR, Kronengold J, Gazula VR, Chen Y, Strumbos JG, Sigworth FJ, Navaratnam D, Kaczmarek LK, Nat Neurosci 2010 13 819 821 10.1038/nn.2563 20512134
122. Regulation of neuronal excitability by interaction of fragile x mental retardation protein with slack potassium channels. Zhang Y, Brown MR, Hyland C, Chen Y, Kronengold J, Fleming MR, Kohn AB, Moroz LL, Kaczmarek LK, J Neurosci 2012 32 15318 15327 10.1523/JNEUROSCI.2162-12.2012 23115170
123. Deletion of Kv4.2 gene eliminates dendritic A-type K+ current and enhances induction of long-term potentiation in hippocampal CA1 pyramidal neurons. Chen X, Yuan LL, Zhao C, Birnbaum SG, Frick A, Jung WE, Schwarz TL, Sweatt JD, Johnston D, J Neurosci 2006 26 12143 12151 10.1523/JNEUROSCI.2667-06. 2006 17122039 (Pubitemid 44808381)
124. K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons. Hoffman DA, Magee JC, Colbert CM, Johnston D, Nature 1997 387 869 875 10.1038/43119 9202119 (Pubitemid 27289580)
125. Dendritic K+ channels contribute to spike-timing dependent long-term potentiation in hippocampal pyramidal neurons. Watanabe S, Hoffman DA, Migliore M, Johnston D, Proc Natl Acad Sci USA 2002 99 8366 8371 10.1073/pnas.122210599 12048251 (Pubitemid 34651058)
126. Rapid, bidirectional remodeling of synaptic NMDA receptor subunit composition by A-type K+ channel activity in hippocampal CA1 pyramidal neurons. Jung SC, Kim J, Hoffman DA, Neuron 2008 60 657 671 10.1016/j.neuron.2008.08.029 19038222
127. Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. Chuang SC, Zhao W, Bauchwitz R, Yan Q, Bianchi R, Wong RK, J Neurosci 2005 25 8048 8055 10.1523/JNEUROSCI.1777-05.2005 16135762 (Pubitemid 41254408)
128. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Krueger DD, Osterweil EK, Chen SP, Tye LD, Bear MF, Proc Natl Acad Sci USA 2011 108 2587 2592 10.1073/pnas.1013855108 21262808
129. Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Bolduc FV, Bell K, Cox H, Broadie KS, Tully T, Nat Neurosci 2008 11 1143 1145 10.1038/nn.2175 18776892